The Trump administration is under fire for snapping up virtually all stocks of remdesivir, the only drug that has been approved to treat coronavirus. California-based Gilead Sciences, which manufactures the drug, announced Monday that the federal government would buy 100% of the company’s projected production for July and 90% of all treatment courses produced in August and September.